AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US.

Revenue climbed 12% to $14.5 billion, the UK drugmaker said Tuesday, beating estimates. Earnings per share excluding some items rose 10% to $2.17, as expected. Under Chief Executive Officer Pascal Soriot’s watch, Astra has turned into an oncology powerhouse and is increasingly focused on the US. Pascal discusses his company's strong quarterly performance and the state of the pharmaceutical industry with Tim Stenovec and Carol Massar on Bloomberg Businessweek Daily.

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US. Revenue climbed 12% to $14.5 billion, the UK drugmaker said Tuesday, beating estimates. Earnings per share excluding some items rose 10% to $2.17, as expected. Under Chief Executive Officer Pascal Soriot&rsquo;s watch, Astra has turned into an oncology powerhouse and is increasingly focused on the US. Pascal discusses his company's strong quarterly performance and the state of the pharmaceutical industry with Tim Stenovec and Carol Massar on Bloomberg Businessweek Daily.

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology. You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology.&nbsp;You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET:&nbsp;<a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

ICYMI: AstraZeneca Profit, Revenue Lifted by Cancer Drugs

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6db3e5d8-e02c-4634-9d65-b32901577bac/transcript

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

 
Chris Beam, Bloomberg Businessweek senior writer discusses his latest piece on how some of the biggest users and supporters of prediction markets are having mixed feelings about its mainstream growth and whether the wide adaptation could dilute its potential to establish collective knowledge. He speaks with Carol Massar and Tim Stenovec.

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.
&nbsp; Chris Beam, Bloomberg Businessweek senior writer discusses his latest piece on how some of the biggest users and supporters of prediction markets are having mixed feelings about its mainstream growth and whether the wide adaptation could dilute its potential to establish collective knowledge. He speaks with Carol Massar and Tim Stenovec.

Prediction Market Theorists Question Kalshi, Polymarket Boom

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/adab560f-026d-4eb0-87e9-b47a0167d8d5/transcript

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. 

Bending Spoons shares surged 40% above their initial public offering price after the company and some of its backers raised $1.68 billion. The trading gives Bending Spoons a market value of $25.7 billion. That compares with a valuation of about $14.5 billion in 2025, after a funding round comprised of $270 million in primary capital and $440 million in secondary capital and a $2.8 billion debt package, according to PitchBook data.  

Bending Spoons was formed in 2013 and derived its name from a scene in the 1990s science-fiction film The Matrix. The company brings a private equity-style playbook to distressed software apps, buying largely subscription-based services, trimming their staff and handing operations to coders

On today's show, Carol and Tim speak with:

Luca Ferrari, Bending Spoons CEO AND Bailey Lipschultz, Bloomberg News IPO Reporter

Todd Gillespie, Bloomberg News Banking Reporter on today’s Big Take: Citi CEO Jane Fraser Brings Troubled Bank Into Trump’s Favor

Lipi Sternheim, CEO, REalloys on a US Army processing facilities partnership

Justin Bibb, Cleveland, OH Mayor (D) on CityLab story: Cleveland Plots an Industrial Comeback on East Side 'Midline'

Jo Ann Corkran, Co-CEO & Managing Partner, Golden Seeds on $200 Million milestone

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.&nbsp;
Bending Spoons shares surged 40% above their initial public offering price after the company and some of its backers raised $1.68 billion. The trading gives Bending Spoons a market value of $25.7 billion. That compares with a valuation of about $14.5 billion in 2025, after a funding round comprised of $270 million in primary capital and $440 million in secondary capital and a $2.8 billion debt package, according to PitchBook data. &nbsp;
Bending Spoons was formed in 2013 and derived its name from a scene in the 1990s science-fiction film The Matrix. The company brings a private equity-style playbook to distressed software apps, buying largely subscription-based services, trimming their staff and handing operations to coders
On today's show, Carol and Tim speak with:
Luca Ferrari, Bending Spoons CEO AND Bailey Lipschultz, Bloomberg News IPO Reporter
Todd Gillespie, Bloomberg News Banking Reporter on today&rsquo;s Big Take: Citi CEO Jane Fraser Brings Troubled Bank Into Trump&rsquo;s Favor
Lipi Sternheim, CEO, REalloys on a US Army processing facilities partnership
Justin Bibb, Cleveland, OH Mayor (D) on CityLab story: Cleveland Plots an Industrial Comeback on East Side 'Midline'
Jo Ann Corkran, Co-CEO &amp; Managing Partner, Golden Seeds on $200 Million milestone

AOL Owner Bending Spoons Jumps 40% After $1.68 Billion IPO

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/36b9d474-9703-4b2a-ba05-b47a0164327f/transcript

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Brett Pulley, Bloomberg News Atlanta Bureau Chief discusses his latest reporting featured in the upcoming Bloomberg Businessweek magazine on how people in southern states are feeling the squeeze as the cost of living rises and wages struggle to keep up. He speaks to hosts Carol Massar and Tim Stenovec.

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. Brett Pulley, Bloomberg News Atlanta Bureau Chief discusses his latest reporting featured in the upcoming Bloomberg Businessweek magazine on how people in southern states are feeling the squeeze as the cost of living rises and wages struggle to keep up. He speaks to hosts Carol Massar and Tim Stenovec.

Rising Costs and Inflation Are Squeezing the US South

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e9bf05d5-3f6f-46b6-bd1d-b479015df6e6/transcript

ICYMI: AstraZeneca Profit, Revenue Lifted by Cancer Drugs

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips